Expression of tetra‐spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with α3β1 integrin

Tetra‐spans transmembrane family (TSTF) members (CD9, CD37, CD53, CD63, CD81 and CD82) have potent effects on cell growth, motility and adhesion in various cells. However, little is known about their expression in human skin. Using immunohistological techniques, we have studied the localization of all six members of TSTF in normal and carcinomatous human keratinocytes. CD9, CD81 and CD82 were expressed in the entire living layers of the epidermis. Their staining pattern was quite similar, and was mainly intercellular with occasional intracellular immunoreactivity. CD53 expression was confined to the intercellular spaces of the upper spinous or granular layer in the normal epidermis. No clear‐cut expression of CD63 could be detected in the epidermis. CD37 was not detected at all. Cultured human keratinocytes also expressed CD9, CD81 and CD82 at the surface membrane of cell‐cell boundaries. Expression of CD37 and CD53 was negative in cultured keratinocyte, while CD63 was clearly localized in the cytoplasmic lysosomes. An immunoprecipitation assay revealed that α3β1 integrin is molecularly associated with CD9. The expression of CD9, CD81 and CD82 was markedly down‐regulated in basal cell carcinoma but not in Bowen's disease. The abundant and differential expression of TSTF molecules and the selective association of CD9 with α3β1 integrin suggest that the TSTF molecules may be involved in the regulation of epidermal differentiation and integrity in vivo.

[1]  O. Yoshie,et al.  Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82. , 1995, Journal of immunology.

[2]  G. Bazzoni,et al.  Specific Association Of CD63 with the VLA-3 and VLA-6 Integrins (*) , 1995, The Journal of Biological Chemistry.

[3]  E. Mekada,et al.  Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites , 1995, The Journal of cell biology.

[4]  M. Klagsbrun,et al.  The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor , 1995, The Journal of cell biology.

[5]  Kenneth M. Yamada,et al.  Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function , 1995, Science.

[6]  C. Boucheix,et al.  CD9 antigen is an accessory subunit of the VLA integrin complexes , 1994, European journal of immunology.

[7]  A. C. Johannessen,et al.  Epithelial expression of HLA class II antigens and Fc gamma receptors in patients with adult periodontitis. , 1994, Journal of clinical periodontology.

[8]  A. Giannetti,et al.  Distinctive integrin expression in the newly forming epidermis during wound healing in humans. , 1993, The Journal of investigative dermatology.

[9]  M. Koyama,et al.  Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA , 1993, The Journal of experimental medicine.

[10]  P. Hersey,et al.  Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma , 1993, International journal of cancer.

[11]  A. Sonnenberg Integrins and their ligands. , 1993, Current topics in microbiology and immunology.

[12]  K. Fukudome,et al.  C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. , 1992, Journal of immunology.

[13]  S. Levy,et al.  The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. , 1992, Journal of immunology.

[14]  V. Horejsi,et al.  Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63 , 1991, FEBS letters.

[15]  G. Stamp,et al.  Distribution of β1, α1, α2 and α3 integrin chains in basal cell carcinomas , 1991 .

[16]  M J Metzelaar,et al.  CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. , 1991, The Journal of biological chemistry.

[17]  W. Carter,et al.  The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells , 1990, Journal of Cell Biology.

[18]  J. Slupsky,et al.  Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. , 1989, The Journal of biological chemistry.

[19]  Y. Nozawa,et al.  Biphasic effects of 12-O-tetradecanoylphorbol-13-acetate on the cell morphology of low calcium-grown human epidermal carcinoma cells: involvement of translocation and down regulation of protein kinase C. , 1988, Cancer research.

[20]  B. Dörken,et al.  The B cell-associated CD37 antigen (gp40-52). Structure and subcellular expression of an extensively glycosylated glycoprotein. , 1988, Journal of immunology.

[21]  M. Greaves,et al.  P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody , 1981, The Journal of experimental medicine.